md-medicaldata


Go to content

Main menu:

 

 

 

 

 

 

 

CIP -  Каталогизација у публикацији
Народна библиотека Србије, Београд
61
MD : Medical Data : medicinska revija = medical review / glavni i odgovorni urednik Dušan Lalošević. - Vol. 1, no. 1 (2009)- . - Zemun : Udruženje za kulturu povezivanja Most Art Jugoslavija ; Novi Sad : Pasterovo društvo, 2009- (Beograd : Scripta Internacional). - 30 cm

Dostupno i na: http://www.md-medicaldata.com. - Tri puta godišnje.

ISSN 1821-1585 = MD. Medical Data
COBISS.SR-ID 158558988


NADZOR PACIJENTA SA TOKSOKARIJAZOM – Prikaz slučaja

DISEASE MONITORING IN TOXOCARIASIS – Case report

Authors

 

Dragana Mijatović1, Nikolina Ćalasan2, Verica Simin1, Dušan Lalošević1
1 Pasterov zavod Novi Sad
2 Dom zdravlja „Novi Sad”

 

• The paper was received on 03.12.2015. / Accepted on 07.12.2015.

 

Abstract

 

Once toxocariasis is diagnosed in a patient, it is customary to proceed with anthelmintic treatment, which is usually carried out with albendazole. However, there is no unequivocal stance on how to assess the effect of the therapy and determine the further examinations that need to be carried out. We report a case of a four-and-a-half year old girl with fever, abdominal pains, slight changes in an EEG recording of temporal range activity, two instances of skin based allergic reactions and eosinophilia of 43%. Toxocariasis was diagnosed via the indirect immunofluorescence test. After two months of albendazole therapy the symptoms vanished, and the antibody titer for T. canis was reduced by 50%. The reduction in antibody titer was followed by a reduction in absolute eosinophil numbers. The patient was monitored over the course of two years. During this time, the antibody titer dropped to barely detectable levels, and the number of eosinophils normalized.

 

 

References

 

  1. Glickman LT, Schantz PM. Epidemiology and patogenesis of zoonotic toxocariasis. Epidemiol. Rev. 1981,3:230-250.
  2. Lalošević D. Mogućnost upotrebe larvi Toxocara canis kao antigena za test indirektne  imunofluorescencije, Magistarski rad, Vojnomedicinska akademija Beograd, 1990, 1-70.
  3. Lalošević D, Lalošević V, Uzurov V, Rončević N, Gebauer E, Sekulić S, Kuzmanović S, Momirovska A. Izbor terapijskog protokola i praćenje efekta terapije albendazolom pacijenata sa toksokarijazom. Med Data Rev 2009;1(3): 65-68.
  4. Rook A, Staughton R. The cutaneous manifestations of toxocariasis. Dermatologica, 1972, 144, 129-143.
  5. Patel SS, Kazura JW. Toxocariasis (Visceral and Ocular Larva Migrans). In: Behrman RE, Kliegman RM and Jenson HB. Nelson Textbook of Pediatrics, 17th ed. W.B. Saunders Company, 2004, p. 1164-66.
  6. Lalošević D, Lalošević V. Toksokarijaza-larva migrans kod čoveka i životinja. Zadužbina Andrejević, Beograd, 2008, 1-105.
  7. Kuzmanović S, Lalošević D. Toksokarijaza i toksoplazmoza kod dvoipogodišnje devojčice. Med Data Rev, 2009,1(3): 55-57.

PDF Mijatović D. • MD-Medical Data 2015;7(4): 327-329

Naslovna | Revija | Galerija | Dešavanja | Instrukcije | Redakcija | Izdavač | Prijatelji sajta | Saradnja | Kontakt | Site Map


Back to content | Back to main menu